Literature DB >> 15842030

Sense of hyper-positive self and response to cognitive therapy in bipolar disorder.

Dominic Lam1, Kim Wright, Pak Sham.   

Abstract

INTRODUCTION: Cognitive therapy (CT) for bipolar disorder emphasizes the monitoring and regulation of mood, thoughts and behaviour. The Sense of Hyper-Positive Self Scale (SHPSS) measures the extent to which bipolar patients value themselves and perceive themselves to possess personal attributes (e.g. dynamism, persuasiveness and productiveness) associated with a state of being 'mildly high', which does not reach the severity of clinical hypomania. It is hypothesized that patients who score highly on the SHPSS do not respond well to cognitive therapy.
METHOD: One hundred and three bipolar-I patients were randomized into CT and control groups. The SHPSS was administered at baseline and at a 6-month follow-up. RESULT: The SHPSS had good test-retest reliability after 6 months. At baseline, the Goal-Attainment Dysfunctional Attitudes contributed significantly to the SHPSS scores after the mood measures were controlled for in a regression analysis. There was a significant interaction between baseline SHPSS scores and group allocation in predicting relapse during therapy. Patients who scored highly on the SHPSS had a significantly increased chance of relapse after controlling for mood scores, levels of social functioning at recruitment, and the previous number of bipolar episodes.
CONCLUSION: Not all patients benefited from CT. For patients with high SHPSS scores, CT was less efficacious. The results also indicate that future studies could evaluate targeting these attributes and dysfunctional beliefs with intensive cognitive behavioural techniques.

Entities:  

Mesh:

Year:  2005        PMID: 15842030     DOI: 10.1017/s0033291704002910

Source DB:  PubMed          Journal:  Psychol Med        ISSN: 0033-2917            Impact factor:   7.723


  29 in total

Review 1.  The behavioral activation system and mania.

Authors:  Sheri L Johnson; Michael D Edge; M Kathleen Holmes; Charles S Carver
Journal:  Annu Rev Clin Psychol       Date:  2011-11-07       Impact factor: 18.561

2.  More than medication-achieving psychotherapy goals in patients with bipolar disorder in challenging settings.

Authors:  Brenda J B Roman; Paulette Marie Gillig
Journal:  Psychiatry (Edgmont)       Date:  2006-03

3.  On the Role of Goal Dysregulation in the Treatment of Bipolar Disorder.

Authors:  David J Miklowitz; Sheri L Johnson
Journal:  Clin Psychol (New York)       Date:  2009-12-01

4.  Behavioral approach system sensitivity and risk taking interact to predict left-frontal EEG asymmetry.

Authors:  Chelsea L Black; Kim E Goldstein; Denise R LaBelle; Christopher W Brown; Eddie Harmon-Jones; Lyn Y Abramson; Lauren B Alloy
Journal:  Behav Ther       Date:  2014-01-30

Review 5.  Identity in bipolar disorder: Self-worth and achievement.

Authors:  Manon L Ironside; Sheri L Johnson; Charles S Carver
Journal:  J Pers       Date:  2019-02-13

6.  Family influences on mania-relevant cognitions and beliefs: a cognitive model of mania and reward.

Authors:  Stephen H Chen; Sheri L Johnson
Journal:  J Clin Psychol       Date:  2012-05-23

7.  Positive Emotional Traits and Ambitious Goals among People at Risk for Mania: The Need for Specificity.

Authors:  June Gruber; Sheri L Johnson
Journal:  Int J Cogn Ther       Date:  2009

8.  Positive overgeneralization and Behavioral Approach System (BAS) sensitivity interact to predict prospective increases in hypomanic symptoms: a behavioral high-risk design.

Authors:  Jonathan P Stange; Ashleigh R Molz; Chelsea L Black; Benjamin G Shapero; Joanna M Bacelli; Lyn Y Abramson; Lauren B Alloy
Journal:  Behav Res Ther       Date:  2012-01-25

Review 9.  The psychopathology and treatment of bipolar disorder.

Authors:  David J Miklowitz; Sheri L Johnson
Journal:  Annu Rev Clin Psychol       Date:  2006       Impact factor: 18.561

10.  Thought suppression in patients with bipolar disorder.

Authors:  David J Miklowitz; Yousra Alatiq; John R Geddes; Guy M Goodwin; J Mark G Williams
Journal:  J Abnorm Psychol       Date:  2010-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.